Mizuho Securities analyst, Ann Hynes, reiterated her Neutral rating on shares of Mednax (NYSE: MD) and cut her price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE